Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NeuCyte Logo
NeuCyte Growth Score
84
CB Rank
181137
Heat Score
64
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.
Founded
obfuscation
PrivateGrant Mountain View, California, United States11-50 www.neucyte.com/
Biopharma
Biotechnology
Clinical Trials
Health Care
Life Science
Neuroscience
Pharmaceutical
Overview

NeuCyte
Total Funding
obfuscation
Growth Score
84
Heat Score
64

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score84
-6 pts
in past quarter
Heat Score 64
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NeuCyte

CB Rank
181137
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.
Founded
obfuscation
PrivateGrant Mountain View, California, United States11-50 www.neucyte.com/
Biopharma
Biotechnology
Clinical Trials
Health Care
Life Science
Neuroscience
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name NEUCYTE, INC.
Operating Status Active
Company Type For Profit
Founders  Jonathan Davila
About the Company
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.
Phone Number (650) 274-8199
Contact Email Enquiries@neucyte.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

SynFire® Technology
A proprietary technology for generating human induced pluripotent stem cell (iPSC)-derived induced neuronal cells for in vitro neural platforms.
In Vitro Human Neural Platform
An in vitro platform using iPSC-derived neural cells for target identification, efficacy testing, neurotoxicity assessment, and disease modeling.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant
obfuscation
Grant - NeuCyte Logo
Grant - NeuCyte
1
obfuscation
National Institute of HealthGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Institute of Health Logo
National Institute of Health
Yes
Grant - NeuCyte Logo
Grant - NeuCyte
—
National Institute of Health Logo
National Institute of Health
Yes
Grant - NeuCyte Logo
Grant - NeuCyte
—
National Institute of Health Logo
National Institute of Health
Yes
Grant - NeuCyte Logo
Grant - NeuCyte
—
National Institute of Health Logo
National Institute of Health
Yes
Grant - NeuCyte Logo
Grant - NeuCyte
—
National Institute of Health Logo
National Institute of Health
Yes
Grant - NeuCyte Logo
Grant - NeuCyte
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 8
News

News and Press

News•Aug 17, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 25, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 24, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,559
635.38%
 in past month

IT Spend

$325.3KThis year, NeuCyte is projected to spend $325.3K on IT, according to Aberdeen.

Active Website Tech Count

3NeuCyte is actively using 3 technologies for its website, according to BuiltWith. These include Viewport Meta, DNSSEC, and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is NeuCyte's headquarters? NeuCyte is located in Mountain View, California, United States.Who invested in NeuCyte? NeuCyte has 4 investors including National Institute of Health and  Leaguer Venture Capital.When was the last funding round for NeuCyte? NeuCyte closed its last funding round on
obfuscation
from a Grant round.Who are NeuCyte's competitors? Alternatives and possible competitors to NeuCyte may include bit.bio, Axol Bioscience, and  TARA Biosystems.How much funding has NeuCyte raised to date? NeuCyte has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|